India, Feb. 12 -- Kala Bio, Inc. (KALA), Wednesday announced the resignation of Chief Executive Officer Mark Iwicki, effective immediately. He will continue to serve as Chair of the Board of Directors of the company.
The company added that its President and Chief Operating Officer Todd Bazemore will be appointed as interim CEO.
Prior to joining the company, Bazemore served as Executive Vice President and Chief Operating Officer of Santhera Pharmaceuticals (USA), Inc.
In the pre-market hours, Kala's stock is moving down 22.17 percent, to $8.47 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....